Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: J Mol Cell Cardiol. 2016 Jun 27;98:73–82. doi: 10.1016/j.yjmcc.2016.06.064

Fig. 5.

Fig. 5

A, a representative example of IBMX inhibitory effect on PDE activity in SANC lysate; B, PDE activity of SANC and LVC lysates in the presence and absence of IBMX; *p < 0.05, versus –IBMX, n = 4 to 7; C, Inhibition of total PDE activity in SANC and LVC by nimodipine (specific for PDE1), Ca2+-dependence of relative nimodipine-sensitive inhibition of total PDE activity; *p < 0.05, #p = 0.0343, n = 3 to 10.